Text
The Human Gut Microbiome Reference Material (RM) promises to standardize and enhance research efforts in a field poised to transform healthcare.
Inflammatory bowel diseases (IBD), such as Crohn’s disease and ulcerative colitis, are long-term conditions involving gut inflammation caused by an excessive immune response. Now, a study done in mice found…
The findings of a recent study suggest a potential role of gut microbiota and microbial metabolites in the link between sugar-sweetened beverages intake and diabetes risk.
MaaT013, a Microbiome Ecosystem Therapy™ (MET), is designed to restore the gut microbiome in pediatric patients aged 6 to 18 years with steroid-resistant aGvHD.
Positive results from Phase 1 trial of BL-001, an innovative live biotherapeutic product (LBP) designed to replicate the metabolic effects of the ketogenic diet.
A new database of thousands of gut microbiota samples from across the word highlights the need for more diverse microbiota research across the globe.
The approval is major step forward in the fight against recurrent C. diff infection.
Certain features of the vaginal microbiota, including specific bacterial communities, could indicate an increased Chlamydia infection risk.
Financing will also support analysis of real-world evidence in people with CF to explore the relationship between P. aeruginosa reduction and clinical outcomes.
Seres Therapeutics, a leader in the live biotherapeutics space, has received pivotal feedback from the U.S. Food and Drug Administration (FDA) regarding the development of its lead investigational treatment, SER-155,…
